Matrix metalloproteinase inhibitors: Present achievements and future prospects
Authors:
- 1 September 1997
- journal article
- review article
- Published by Springer Nature in Investigational New Drugs
- Vol. 15 (3) , 175-185
Abstract
Matrix metalloproteinases (MMPs) are a class of structurally related enzymes that function in the degradation of extracellular matrix proteins that constitute the pericellular connective tissue and...Keywords
This publication has 78 references indexed in Scilit:
- Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancerEuropean Journal of Cancer, 1996
- Effect of Matrix Metalloproteinase Inhibitor Batimastat on Breast Cancer Regrowth and Metastasis in Athymic MiceJNCI: Journal of the National Cancer Institute, 1995
- Inhibition of the metastatic spread and growth of B16‐BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitorInternational Journal of Cancer, 1994
- Protease inhibitors: Role and potential therapeutic use in human cancerEuropean Journal of Cancer, 1994
- Tumor Cell Interactions with the Extracellular Matrix During Invasion and MetastasisAnnual Review of Cell Biology, 1993
- Mechanisms of tissue destruction and cellular activation in rheumatoid arthritisCurrent Opinion in Rheumatology, 1992
- The origin of matrix metalloproteinases and their familial relationshipsFEBS Letters, 1991
- Inhibition of human collagenases by sulfur-based substrate analogsBiochemical and Biophysical Research Communications, 1991
- A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomasNature, 1990
- Human and rat malignant-tumor-associated mRNAs encode stromelysin-like metalloproteinasesBiochemistry, 1989